Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 4/20 | 0.46 |
| ▸ | CCR8 | P51685 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 9/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | COMT | P21964 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 3/20 | 0.37 |
| ▸ | CCR5 | P51681 | 2/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14508241 | 1.00 | CCR1 (0.46) | CCR1CCR8L3MBTL1PIK3CDCYP2C9 | |
| SCHEMBL14508250 | 0.93 | PIK3CD (0.40) | CCR1CCR8L3MBTL1PIK3CDCYP2C9 | |
| SCHEMBL21395964 | 0.86 | CCR1 (0.40) | CCR1CCR8L3MBTL1ALDH1A1MAPT | |
| SCHEMBL14508242 | 0.85 | BRD4 (0.48) | CCR1CCR8L3MBTL1CYP2C9ALDH1A1 | |
| SCHEMBL14508255 | 0.85 | BRD4 (0.48) | CCR1CCR8L3MBTL1CYP2C9ALDH1A1 | |
| SCHEMBL11914323 | 0.84 | CCR1 (0.41) | CCR1CCR8L3MBTL1PIK3CDALDH1A1 | |
| SCHEMBL14508272 | 0.84 | BRD4 (0.47) | CCR1CCR8L3MBTL1CYP2C9ALDH1A1 | |
| SCHEMBL14508283 | 0.84 | BRD4 (0.47) | CCR1CCR8L3MBTL1CYP2C9ALDH1A1 | |
| SCHEMBL21395961 | 0.83 | CCR1 (0.40) | CCR1CCR8L3MBTL1ALDH1A1MAPT | |
| SCHEMBL18806863 | 0.83 | CCR1 (0.58) | CCR1CCR8L3MBTL1PIK3CDCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070122652-A1 | Compound and organic electroluminescent device using same | CANON KABUSHIKI KAISHA (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122652-A1 | Compound and organic electroluminescent device using same | OR10J3, LEF1, RPL19 | CCR1 531/4885CCR8 285/4885L3MBTL1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.